Pharmaceuticals News and Research

RSS

tPA therapy improves outcomes for patients suffering acute ischemic stroke

Administering a clot-dissolving drug to stroke victims quickly — ideally within the first 60 minutes after they arrive at a hospital emergency room — is crucial to saving their lives, preserving their brain function and reducing disability.

23 Apr 2014

Stronger incentives for medical innovators can reduce health care spending, say researchers

To help rein in massive health care spending, a new RAND study concludes that U.S. policy makers should urgently find ways to incentivize pharmaceutical companies and device makers to develop products that produce more value.

23 Apr 2014

Novartis to buy Glaxosmithkline's oncology unit

The deal, worth billions, will also see Novartis sell its vaccines unit to Glaxo and partner with Glaxo on their consumer divisions. Novartis also said it will sell its animal health division to Eli Lily.

23 Apr 2014

Avedro receives Canadian approval for KXL II System

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.

23 Apr 2014

NeuroPhage engineers series of molecules with potential to treat most neurodegenerative diseases

Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.

23 Apr 2014

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer Inc. announced today top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079), evaluating the efficacy and safety of tofacitinib, an oral Janus kinase (JAK) inhibitor, the first in a new class of medicines being investigated for the treatment of moderate-to-severe plaque psoriasis.

23 Apr 2014

Catheter coating: an interview with Dr. Hinke Malda, Director of Medical Coatings, DSM Biomedical

DSM’s biomedical work brings new material innovation to market through the development of novel materials-based solutions that meet the present and future needs of the medical device and pharmaceutical industries.

22 Apr 2014

STEM-Pharma delivers evidence-based recommendations on pharmaceutical growth in emerging markets

STEM-Pharma is a management consulting firm specialized in healthcare and pharmaceutical market intelligence. The company delivers evidence-based recommendations on pharmaceutical growth opportunities in emerging markets.

22 Apr 2014

First Edition: April 22, 2014

Today's early morning highlights from the major news organizations, including marketplace news about the Novartis purchase of GlaxoSmithKline's oncology unit for $14.5 billion.

22 Apr 2014

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.

22 Apr 2014

Vietnam's pharmaceutical market records growth rate of nearly 17% in 2013

Decision Resources Group finds that Vietnam is currently one of the fastest growing pharmaceutical markets in Southeast Asia, recording a growth rate of nearly 17 percent and exceeding $3 billion in size in 2013. Increasing affluence, a rapidly aging population and the steady extension of public health insurance are among factors that are driving demand for prescription medicines.

22 Apr 2014

‘Profile America’ features world's most important medicine, insulin

One of world's most important medicines — insulin —became available for general use this month in 1923, saving the lives of millions of people suffering from diabetes. Insulin is a hormone produced by the pancreas and is critical in the processing of carbohydrates in the human body. I

22 Apr 2014

Allergan notes public filings made by Pershing Square and Valeant Pharmaceuticals

Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.

22 Apr 2014

Shiseido Cell-Processing and Expansion Center to be opened in Kobe, Japan

Shiseido Co., Ltd. announces plans to open the Shiseido Cell-Processing and Expansion Center (SPEC) on May 1, 2014. The center, located in the in the Kobe Biomedical Innovation Cluster in Kobe, Japan, will centralize research and development on hair regenerative medicine with an aim toward commercialization.

22 Apr 2014

Global Generic Drugs market to grow at 11.02% CAGR over 2013-2018

Global Information Inc. announces the addition of a new market research report "Global Generic Drugs Market 2014-2018" at GIIResearch.com

21 Apr 2014

Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI).

21 Apr 2014

Synageva announces publication of LAL Deficiency review in Atherosclerosis

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced the publication of an overview of lysosomal acid lipase deficiency (LAL Deficiency) in the online version and an upcoming print edition of Atherosclerosis, the official journal of the European Atherosclerosis Society.

21 Apr 2014

Blog explains why NeutroPhase can play important role in treating 'flesh-eating' infections

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that WoundSource™ has highlighted NovaBay's NeutroPhase wound cleanser in a recent blog posting. The blog explains why NeutroPhase can play an important role in treating life-threatening necrotizing fasciitis, or 'flesh-eating' infections.

21 Apr 2014

PrimeVigilance wins 2014 Queen's Award for Enterprise in International Trade Category

PrimeVigilance Limited (PrimeVigilance), the specialist pharmacovigilance service provider, has been honoured with the Queen's Award for Enterprise 2014 in the International Trade Category.

21 Apr 2014

FDA and EC grant Orphan Drug Designation to Boehringer’s volasertib for acute myeloid leukemia

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML).

21 Apr 2014

Pharmaceuticals News and Research

tPA therapy improves outcomes for patients suffering acute ischemic stroke

Stronger incentives for medical innovators can reduce health care spending, say researchers

Novartis to buy Glaxosmithkline's oncology unit

Avedro receives Canadian approval for KXL II System

NeuroPhage engineers series of molecules with potential to treat most neurodegenerative diseases

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Catheter coating: an interview with Dr. Hinke Malda, Director of Medical Coatings, DSM Biomedical

STEM-Pharma delivers evidence-based recommendations on pharmaceutical growth in emerging markets

First Edition: April 22, 2014

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Vietnam's pharmaceutical market records growth rate of nearly 17% in 2013

‘Profile America’ features world's most important medicine, insulin

Allergan notes public filings made by Pershing Square and Valeant Pharmaceuticals

Shiseido Cell-Processing and Expansion Center to be opened in Kobe, Japan

Global Generic Drugs market to grow at 11.02% CAGR over 2013-2018

Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

Synageva announces publication of LAL Deficiency review in Atherosclerosis

Blog explains why NeutroPhase can play important role in treating 'flesh-eating' infections

PrimeVigilance wins 2014 Queen's Award for Enterprise in International Trade Category

FDA and EC grant Orphan Drug Designation to Boehringer’s volasertib for acute myeloid leukemia

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence